Get started
Author

Satish Kumar

Correlation of salivary glucose, blood glucose and oral candidal carriage in the saliva of type 2 diabetics: A case-control study
2014 · Satish Kumar, S Padmashree, et al. · Contemporary Clinical Dentistry · 81
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients
2015 · Saif S. Ahmad, Wendi Qian, et al. · Melanoma Research · 53
Fucose: A biomarker in grading of oral cancer
2015 · Mona Saxena, Satish Kumar, et al. · National Journal of Maxillofacial Surgery · 22
PDF
Oral submucous fibrosis: A demographic study
2016 · Satish Kumar · Journal of Indian Academy of Oral Medicine and Radiology · 20
A dermatoglyphic study in oral submucous fibrosis patients
2014 · Satish Kumar, Srinivas Kandakurti, et al. · Journal of Indian Academy of Oral Medicine and Radiology · 15
Oral mucosal disorder-A demographic study
2020 · Satish Kumar, Ankit Suhag, et al. · Journal of Family Medicine and Primary Care · 6
Serum fucose level in oral cancer, leukoplakia, and oral sub mucous fibrosis: A biochemical study
2019 · Satish Kumar, Ankit Suhag, et al. · Journal of Family Medicine and Primary Care · 5
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study
2025 · Paul Lorigan, Theresa Michelle Medina, et al. · European Journal of Cancer · 4
Abstract LB214: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label Phase 2 SCOPE Trial
2025 · Heather Shaw, Poulam Patel, et al. · Cancer Research · 2
1325 SCOPE, an open label phase 2 parallel multi cohort clinical trial evaluating an off-the-shelf DNA plasmid vaccine in first line advanced melanoma combined with checkpoint blockade – interim read-out
2025 · Nermeen Varawalla, Heather Shaw, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract B119: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab induces functional CD4 and CD8 T cell responses in patients with advanced unresectable melanoma
2025 · Joseph Chadwick, Gaëlle Cane, et al. · Cancer Immunology Research
Abstract CT024: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label Phase 2 SCOPE Trial
2024 · Heather Shaw, Poulam Patel, et al. · Cancer Research
3-Dimensional Printing In Oral And Maxillofacial Surgery-Techniques And Clinical Applications
2021 · Gayathri, B Sreeja, et al. · Journal of Emerging Technologies and Innovative Research
Carcinoma Breast, Oestrogen Receptor, Progesterone Receptor.
2016 · B. Raj Siddarth, Anil Kumar, et al.
Works count: 14
Citation count: 208
H-index: 6
I10-index: 5
Year
Topic
Type